← Open Payments lookup

ANNA KAVANAUGH: Open Payments

NPI 1962827345 · NEWBURGH, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,059 in 39 payments from 13 companies in 2025. Trend: 2023 $572 · 2024 $810 · 2025 $1,059

Food & beverage: $970Education: $89
CompanyPaymentsAmount
Regeneron Healthcare Solutions, Inc.7$257
Galderma Laboratories, L.P.4$223
GENZYME CORPORATION4$98
Novartis Pharmaceuticals Corporation5$97
Amgen Inc.4$92
GlaxoSmithKline, LLC.5$86
Genentech USA, Inc.2$48
Takeda Pharmaceuticals U.S.A., Inc.2$39
CSL Behring2$35
ARS Pharmaceuticals Operations, Inc.1$28

Products named: DUPIXENT, NEMLUVIO, TEZSPIRE, TRELEGY ELLIPTA, Rhapsido, Xolair, TAKHZYRO, NEFFY.

Industry payments across IN — which companies pay providers there.